Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tongxinluo capsule (TXLC) is a widely used traditional Chinese medicine for coronary heart disease (CHD). However, the efficacy and safety of different courses of TXLC for CHD after percutaneous coronary intervention (PCI) have not been systematically evaluated yet. The Cochrane Library, PubMed, Emb...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Jiaqi, Yuan, Rong, Li, Pengqi, Xin, Qiqi, Miao, Yu, Shen, Xiaoxu, Xu, Fengqin, Cong, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181557/
https://www.ncbi.nlm.nih.gov/pubmed/35683377
http://dx.doi.org/10.3390/jcm11112991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181557/
https://www.ncbi.nlm.nih.gov/pubmed/35683377
http://dx.doi.org/10.3390/jcm11112991

Ejemplares similares